本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Alpha Tau Medical

3.07
-0.0500-1.60%
成交量:9,156.00
成交额:2.82万
市值:2.60亿
市盈率:-6.63
高:3.13
开:3.10
低:3.05
收:3.12
数据加载中...
2025/03/12

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/12

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/03/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/07

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/07

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/12/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/20

SEC问询函

Form CORRESP - Correspondence
2023/06/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/04/11

SEC问询函

CORRESP [Cover] - Correspondence
2023/03/23

[修订]年度报告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/03/09

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/03/09

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/05/18

SEC问询函

CORRESP [Cover] - Correspondence
2022/05/03

SEC问询函

CORRESP [Cover] - Correspondence
2022/05/03

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers